mechanisms in a formerly sectorally separated health care system. These reforms marked the launch of managed care in Germany that … on the structure of health care expenditure in Germany during the start-up phase of managed care from 2004 to 2008. We …

mechanisms in a formerly sectorally separated health care system. These reforms marked the launch of managed care in Germany that … on the structure of health care expenditure in Germany during the start-up phase of managed care from 2004 to 2008. We …

-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference … co-payments. We use quarterly data on reference priced drugs covered by the social health insurance in Germany over the …

Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit … assessment in Germany since its introduction in 2011 up to September 2016. Methods: It was differentiated between additive (new …